Watchlist Price Alert

Forma Therapeutics Inc. (FMTX)

NASDAQ: FMTX · Real-Time Price · USD

20.01

0.00 (0.00%)

At close: Oct 13, 2022, 8:00 PM

Forma Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.44M	3.38M	17.73M	72.01M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.44M	3.38M	17.73M	72.01M
Operating Income	-51.99M	-43.87M	-50.09M	-43.43M	-44.06M	-36.21M	-32.81M	-32.24M	-26.94M	-32.23M	-26.04M	-31.75M	-16.88M	34.22M
Interest Income	599K	289K	284K	216K	309K	262K	1.02M	870K	895K	641K	306K	565K	782K	1.2M
Pretax Income	-52.59M	-44.16M	-50.09M	-43.29M	-43.48M	-35.95M	-31.78M	-31.42M	-28.68M	-8.26M	-25.29M	-30.98M	-16.08M	35.71M
Net Income	-52.58M	-44.16M	-50.13M	-43.29M	-43.59M	-35.96M	-28.59M	-27.62M	-25.44M	11.23M	-24.66M	-30.98M	-14.76M	35.6M
Selling & General & Admin	13.94M	13.14M	13.24M	12.75M	12.47M	9.87M	7.94M	7.46M	6.45M	8.93M	6.77M	7.03M	5.69M	4.92M
Research & Development	39.06M	31.27M	37.05M	30.68M	31.59M	26.34M	24.87M	24.78M	20.51M	23.21M	27.04M	27.56M	28.07M	28.65M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	53M	44.41M	50.28M	43.43M	44.06M	36.21M	32.81M	32.24M	26.96M	32.14M	33.81M	34.58M	33.75M	33.57M
Interest Expense	599K	289K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	53M	44.41M	50.28M	43.43M	44.06M	36.21M	32.81M	32.24M	26.96M	32.14M	33.81M	34.58M	33.75M	33.57M
Income Tax Expense	-13K	3K	31K	7K	108K	8K	-3.19M	-3.81M	-3.24M	-19.48M	-631K	766K	-1.32M	108K
Shares Outstanding (Basic)	47.81M	47.56M	47.39M	47.37M	47.34M	47.3M	42.24M	41.09M	5.94M	24.99M	24.99M	24.99M	24.99M	24.99M
Shares Outstanding (Diluted)	47.81M	47.56M	47.39M	47.37M	47.34M	47.3M	42.24M	41.09M	5.94M	27.04M	24.99M	27.04M	27.04M	27.04M
EPS (Basic)	-1.1	-0.93	-1.06	-0.91	-0.92	-0.76	-0.68	-0.67	-4.28	0.45	-0.99	-1.24	-0.59	1.42
EPS (Diluted)	-1.1	-0.93	-1.06	-0.91	-0.92	-0.76	-0.68	-0.67	-4.28	0.42	-0.99	-1.15	-0.55	1.32
EBITDA	-51.28M	-43.23M	-49.2M	-42.98M	-43.3M	-35.77M	-31.58M	-31.17M	-28.39M	-7.71M	-24.75M	-30.39M	-15.4M	36.57M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	715K	638K	897K	312K	177K	183K	200K	249K	284K	543K	540K	591K	682K	855K